Table 1.
Clinical characteristics of T2D patients in the two prospective cohorts
| JKS (n = 416) | GMS (n = 826) | |
|---|---|---|
| Males (%) | 57.0 | 49.3 |
| Age at study entry (years) | 57.6 ± 9.5 | 62.3 ± 9.7 |
| Age at diabetes diagnosis (years) | 43.8 ± 9.0 | 51.3 ± 10.4 |
| Diabetes duration (years) | 13.9 ± 8.0 | 11.0 ± 9.1 |
| BMI (kg/m2) | 29.9 ± 6.5 | 31.0 ± 5.8 |
| HbA1c (%) | 8.40 ± 1.6 | 8.65 ± 1.9 |
| CKD | 71 (17.5) | 144 (17.8) |
| Albuminuria | ||
| Normoalbuminuria | 217 (52.1) | 546 (69.5) |
| Microalbuminuria | 114 (27.4) | 196 (24.9) |
| Macroalbuminuria | 85 (20.4) | 44 (5.6) |
| Glucose-lowering therapy | ||
| Diet only | 31 (7.5) | 137 (18.6) |
| Oral agents | 119 (28.6) | 344 (41.6) |
| Insulin with/without oral agents | 266 (63.9) | 345 (41.8) |
| Follow-up | ||
| Years | 12.8 ± 5.8 | 7.5 ± 2.2 |
| py | 5,340.2 | 6,165.6 |
| Deaths, n (%) | 215 (51.7) | 164 (19.9) |
Continuous variables are reported as the mean ± SD; categorical variables are reported as total frequencies, with percentages in parentheses.